IP Library › Granted Patent US 7,951,395
Granted Patent B2
US 7,951,395 · App. 10/332,547 · Granted May 31, 2011

Dermal application system for aminolaevulinic acid

Assignee: Photonamic GmbH & Co. KG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,951,395
App. No.
10/332,547
Granted
May 31, 2011
Kind
B2
Abstract

The invention relates to a dermal for aminolaevulinic acid, wherein a self-adhesive matrix system is used containing crystalline aminolaevulinic acids.

Claims (5)

1. A dermal application system, which is a self-adhesive matrix system, consisting of aminolaevulinic acid (ALA) hydrochloride crystals suspended in a polymer matrix, wherein the polymer matrix consists of polymers from the group consisting of acrylates, and polyisobutylene, wherein a substantial amount of the ALA hydrochloride crystals have a mean diameter of 20 μm to 200 μm.

2. Application system according to claim 1 , characterized in that the ALA hydrochloride crystals have a mean diameter of 30 μm to 190 μm.

3. Application system according to claim 2 , characterized in that the ALA hydrochloride crystals have a mean diameter of 90 μm to 160 μm.

4. Application system according to claim 1 , characterized in that the ALA hydrochloride is present in a concentration of 1 to 50 wt. % relative to the polymer matrix.

5. Application system according to claim 1 , characterized in that it releases at least 30% of the ALA hydrochloride within 30 minutes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2003
From: LEE, GEOFFREY; SZEIMIES, ROLF-MARKUS
To: PHOTONAMIC GMBH & CO., KG
Reel/Frame 014020/0935 →
Priority Claims (1)
DE 100346731 · Jul 17, 2000 · national
Continuity (1)
Related Publication 20050013852A1 · Jan 20, 2005